Co-administration of Iloprost and Eptifibatide in Septic Shock Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Septic Shock
Interventions
DRUG

Iloprost+eptifibatide

DRUG

Placebo

Trial Locations (1)

DK-3400

Department of Anesthesia and Intensive Care, Nordsjællands Hospital, Hillerød

All Listed Sponsors
lead

Sisse R. Ostrowski, MD PhD DMSc

OTHER

NCT02204852 - Co-administration of Iloprost and Eptifibatide in Septic Shock Patients | Biotech Hunter | Biotech Hunter